Research and Clinical Trials

Mark McNiven, Ph.D., and Tanios Bekaii-Saab, M.D., Mayo Clinic Comprehensive Cancer Center researchers, explain what cancer is, how it develops and why it's challenging to treat.

Findings show extended progression-free survival for people with meningiomas who received a radiopharmaceutical approved for neuroendocrine tumors.

Mayo Clinic study findings reveal a protein that increases glioblastoma malignancy, a new understanding of the tumor's biology, and a potential new treatment strategy.

Dr. Elizabeth Cathcart-Rake explains the value of specialized cancer care for LGBTQ+ people and how she hopes to pave the way for improved outcomes with the Rainbows Breast Cancer Clinic.

Researchers have uncovered a new reason CAR-T cell therapy fails in some patients, fueling new strategies to improve the treatment's outcome.

A new study shows people with monoclonal B-cell lymphocytosis (MBL) may have an elevated risk for several health complications, including melanoma.

After a history-making larynx transplant at Mayo Clinic, Marty Kedian is back home in the Boston area and drawing attention with his gift for gab.

New Mayo Clinic research represents a promising step toward identifying biological signals or biomarkers that may aid in early detection.

Study results showed significantly higher survival rates when blinatumomab was added to chemotherapy for people with B-cell acute lymphoblastic leukemia.

Research shows screening protocols fail to catch a notable number of people carrying genetic mutations associated with increased cancer risk.